Literature DB >> 11797312

North Carolina macular dystrophy: clinicopathologic correlation.

K W Small1, I Voo, J Flannery, N Udar, B J Glasgow.   

Abstract

PURPOSE: To describe the clinical and histopathologic findings in a 72-year-old woman with North Carolina macular dystrophy.
METHODS: Clinical examination was performed by slit-lamp biomicroscopy, indirect ophthalmoscopy, color fundus photography, and focal electroretinography. Histopathologic examination of the enucleated left eye consisted of light microscopy.
RESULTS: Light microscopy demonstrated a discrete macular lesion characterized by focal absence of photoreceptor cells and retinal pigment epithelium. Bruch's membrane was attenuated in the center of the lesion and associated with marked atrophy of the choriocapillaris. Adjacent to the central lesion, some lipofuscin was identified in the retinal pigment epithelium.
CONCLUSIONS: North Carolina macular dystrophy has both clinical and microscopic appearances of a well-demarcated retinal and pigment epithelial lesion confined to the macula. This is consistent with the clinical impression that it is a focal macular dystrophy.

Entities:  

Mesh:

Year:  2001        PMID: 11797312      PMCID: PMC1359015     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  13 in total

1.  Histopathology of incipient fundus flavimaculatus.

Authors:  R L Steinmetz; A Garner; J I Maguire; A C Bird
Journal:  Ophthalmology       Date:  1991-06       Impact factor: 12.079

2.  North Carolina macular dystrophy: clinical features, genealogy, and genetic linkage analysis.

Authors:  K W Small
Journal:  Trans Am Ophthalmol Soc       Date:  1998

3.  Adult-onset foveomacular pigment epithelial dystrophy: clinicopathologic correlation of three cases.

Authors:  S R Dubovy; R J Hairston; H Schatz; A P Schachat; N M Bressler; D Finkelstein; W R Green
Journal:  Retina       Date:  2000       Impact factor: 4.256

4.  Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus.

Authors:  C D Birnbach; M Järveläinen; D E Possin; A H Milam
Journal:  Ophthalmology       Date:  1994-07       Impact factor: 12.079

5.  Retinal pigment epithelial abnormalities in fundus flavimaculatus: a light and electron microscopic study.

Authors:  R C Eagle; A C Lucier; V B Bernardino; M Yanoff
Journal:  Ophthalmology       Date:  1980-12       Impact factor: 12.079

6.  A histopathologic study of Best's macular dystrophy.

Authors:  G T Frangieh; W R Green; S L Fine
Journal:  Arch Ophthalmol       Date:  1982-07

7.  Histopathology of Best's macular dystrophy.

Authors:  T A Weingeist; J L Kobrin; R C Watzke
Journal:  Arch Ophthalmol       Date:  1982-07

8.  Foveomacular vitelliform dystrophy, adult type. A clinicopathologic study including electron microscopic observations.

Authors:  J R Patrinely; R A Lewis; R L Font
Journal:  Ophthalmology       Date:  1985-12       Impact factor: 12.079

9.  Fundus flavimaculatus without maculopathy. A clinicopathologic study.

Authors:  P J McDonnell; J D Kivlin; I H Maumenee; W R Green
Journal:  Ophthalmology       Date:  1986-01       Impact factor: 12.079

10.  Autosomal-dominant fundus flavimaculatus. Clinicopathologic correlation.

Authors:  P F Lopez; I H Maumenee; Z de la Cruz; W R Green
Journal:  Ophthalmology       Date:  1990-06       Impact factor: 12.079

View more
  3 in total

1.  Clinical and genetic characterization of a Danish family with North Carolina macular dystrophy.

Authors:  Thomas Rosenberg; Ben Roos; Thorkild Johnsen; Niels Bech; Todd E Scheetz; Michael Larsen; Edwin M Stone; John H Fingert
Journal:  Mol Vis       Date:  2010-12-09       Impact factor: 2.367

2.  Congenital toxoplasmosis as one phenocopy of North Carolina Macular Dystrophy (NCMD/MCDR1).

Authors:  Kent W Small; Andrea L Vincent; Chelsey L Knapper; Fadi S Shaya
Journal:  Am J Ophthalmol Case Rep       Date:  2019-07-16

3.  A novel duplication involving PRDM13 in a Turkish family supports its role in North Carolina macular dystrophy (NCMD/MCDR1).

Authors:  Kent W Small; Stijn Van de Sompele; Karen Nuytemans; Andrea Vincent; Ozge Ozalp Yuregir; Emine Ciloglu; Cahfer Sariyildiz; Toon Rosseel; Jessica Avetisjan; Nitin Udar; Jeffery M Vance; Margaret A Pericak-Vance; Elfride De Baere; Fadi S Shaya
Journal:  Mol Vis       Date:  2021-09-01       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.